Koyfin Home > Directory > Health Care > Aduro Biotech > Net Change in Cash

Aduro Biotech Net Change in Cash Chart (ADRO)

Aduro Biotech annual/quarterly Net Change in Cash from 2013 to 2020.
  • Aduro Biotech Net Change in Cash for the quarter ending June 06, 2020 was $-23m a -11.50% increase of 3m year over year
  • Aduro Biotech Net Change in Cash for the last 12 months ending June 06, 2020 was $-8m a -693.88% increase of 59m year over year
  • Aduro Biotech Annual Net Change in Cash for 2019 was $-67m a 53.06% decrease of -35m from 2018
  • Aduro Biotech Annual Net Change in Cash for 2018 was $-31m a 364.13% decrease of -114m from 2017
  • Aduro Biotech Annual Net Change in Cash for 2017 was $83m a 190.78% increase of 158m from 2016
Other Cash Flow Metrics:
  • Aduro Biotech Cash Flow from Operations for the quarter ending December 12, 2018 was $-1m a -1,784.81% increase of 20m year over year
  • Aduro Biotech Levered Free Cash Flow (FCF) for the quarter ending December 12, 2018 was $-23m a 36.84% decrease of -8m year over year
  • Aduro Biotech Total Revenue for the quarter ending December 12, 2018 was $3m a -140.28% decrease of -4m year over year
View Chart On Koyfin

Quarterly ADRO Net Change in Cash Data

06/2020$-23m
03/2020$35m
12/2019$6m
09/2019$-26m
06/2019$-34m
03/2019$-13m
12/2018$6m
09/2018$6m
06/2018$14m
03/2018$-57m

Annual ADRO Net Change in Cash Data

2019$-67m
2018$-31m
2017$83m
2016$-75m
2015$31m
2014$111m
2013$5m
2012$-3m